Oligo Synthesis : CEPs
Prices quoted are for single packs only. For multiples of the same product please request a quote. Some of Glen"sproductsarehazardousandmay be subject to additional shipping charges. Full product information is available onGlen Research"s website.
pdC-CE Phosphoramidite
pdC-CE Phosphoramidite
Glen Research
| Catalogue No. | Description | Pack Size | Price | Qty |
|
|---|---|---|---|---|---|
| 10-1014-02 | pdC-CE Phosphoramidite | 0.25g | £196.00£186.20Offer until : 31-Mar-2021Offer Code : GLEN5View Offer | Quantity | Add to Order |
| 10-1014-05 | pdC-CE Phosphoramidite | 0.5g | £392.00£372.40Offer until : 31-Mar-2021Offer Code : GLEN5View Offer | Quantity | Add to Order |
| 10-1014-90 | pdC-CE Phosphoramidite | 100µmoles | £88.00£64.60Offer until : 31-Mar-2021Offer Code : GLEN5View Offer | Quantity | Add to Order |
Related products
pdC-CE Phosphoramidite
pdC-CE Phosphoramidite
Glen Research
| pdC-CE Phosphoramidite |
Catalog Number: 10-1014-xx
Description: pdC-CE Phosphoramidite
| 5"-Dimethoxytrityl-N4-diisobutylaminomethylidene-5-(1-Propynyl)-2"-deoxyCytidine,3"-[(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite | ||
| Formula: C51H67N6O7P | M.W.: 907.1 | F.W.: 327.23 |
Diluent: Anhydrous Acetonitrile |
| Coupling: No changes needed from standard method recommended by synthesizer manufacturer. |
| Deprotection: Deprotection in Ammonium Hydroxide requires a minimum of 12 hours at 55 °C. |
| Storage: Refrigerated storage, maximum of 2-8°C, dry |
| Stability in Solution: Similar to dA,C,G,T-CE Phosphoramidites |
| Please Note: This product is covered by patents or patents pending owned by Isis Pharmaceuticals, Inc. ("Isis"). Purchase of this product includes a limited license to use this product solely for internal research. This license specifically excludes (and you have no right to use this product for): (a) therapeutic or diagnostic applications (including products or services that incorporate this product), (b) any in vivo toxicity/safety study in support of an investigational new drug application (or foreign counterpart), (c) resale (including sale of any products or services that incorporate this product) or (d) gene functionalization activities (including products or services that incorporate data derived from gene functionalization activities) if such activities have commercial application, any and all of which require a separate license from Isis. Neither this product nor any product created through its use may be used in human clinical trials. |
| Please see Terms and Conditions of Use |
C-5 PROPYNE DERIVATIVES AND G-CLAMP
Substitution of C-5 propynyl-dC (pdC) for dC and C-5 propynyl-dU (pdU) for dT are effective strategies to enhance base pairing. Using these base substitutions, duplex stability and melting temperatures are raised by the following amounts: C-5 propynyl-C 2.8° per substitution; C-5 propynyl-U 1.7° per substitution. AP-dC (G-clamp) substitutes for dC and is another very important modified nucleoside that enhances hybridization by 7.5° per substitution. The ability of these modified bases to enhance binding while maintaining specificity has proven useful in antisense research and in the synthesis of high affinity probes. AP-dC is also a fluorescent nucleoside and should find uses in DNA structural research.
If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200
pdC-CE Phosphoramidite
pdC-CE Phosphoramidite
Glen Research
Material Safety Data Sheet
Glen Report 9.1: A NOVEL TRANSFECTION REAGENT
Glen Report 6.2: C-5 PROPYNE DERIVATIVES - ANTISENSE BREAKTHROUGH?
Glen Report 10.1: CYTOFECTIN GSV TRANSFECTION PROTOCOL
Glen Report 11.1: USING MODIFIED BASES TO OPTIMIZE HYBRIDIZATION
Glen Report 13.1: C-5 PROPYNES, CYTOFECTIN AND OTHER PRODUCT UPDATES
If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200
pdC-CE Phosphoramidite
pdC-CE Phosphoramidite
Glen Research
C-5 Propyne and AP-dC Phosphoramidites
This product is covered by patents or patents pending owned by Isis Pharmaceuticals, Inc. (Isis). Purchase of this product includes a limited licence to use this product solely for internal research. This licence specifically excludes (an you have no right to use this product for): (a) therapeutic or diagnostic applications (including products or services that incorporate this product), (b) any in vivo toxicity/safety study in support of an investigational new drug application (or foreigh counterpart), (c) resale (including sale of any products or services that incorporate this product), or (d) gene functionalisation activities (including products or services that incorporate data derived from gene functionalisation activities) if such activities have commercial application, any and all of which require a separate licence from Isis. Neither this product nor any product created through its use may be used in human clinical trials.
A simple agreement must be signed before end-users and custom oligo services amy purchase these products for use as defined above.
FREQUENTLY ASKED TECHNICAL QUESTION
QUESTION: What are the extinction coefficients for propynyl-dC and dU? Also Halogenated dC and dU derivatives? Others?
RESPONSE:See:Table of Extinction Coefficients
REFERENCE(S):B. Froehler, GileadM. PowellR. Somers
If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200
pdC-CE Phosphoramidite
pdC-CE Phosphoramidite
Glen Research
EXTINCTION DATA
| Item | Nucleoside | λMax-1 | Emax-1 | λMax-2 | Emax-2 | E260 |
| (nm) | (ml/µmole) | nm | (ml/µmole) | (ml/µmole) | ||
| 10-1014 | pdC | 295 | 7.7 | 234 | 14.7 | 5.1 |
DILUTION/COUPLING DATA
The table below shows pack size data and, for solutions, dilutions and approximate couplings based on normal priming procedures. Please link formore detailed usage informationwith the various synthesizers.
| ABI 392/394 | |||||||||
| Cat.No. | PackSize | Grams/Pack | 0.1M Dil.(mL) | LV40 | LV200 | 40nm | 0.2µm | 1µm | 10µm |
| Approximate Number of Additions | |||||||||
| 10-1014-02 | 0.25grams | .25grams | 2.76 | 78.67 | 47.2 | 29.5 | 21.45 | 15.73 | 3.93 |
| 10-1014-05 | 0.5grams | .5grams | 5.51 | 170.33 | 102.2 | 63.88 | 46.45 | 34.07 | 8.52 |
| 10-1014-90 | 100µmoles | .091grams | 1 | 20 | 12 | 7.5 | 5.45 | 4 | 1 |
| Expedite | |||||||||
| Cat.No. | PackSize | Grams/Pack | Dilution(mL) | Molarity | 50nm | 0.2µm | 1µm | 15µm | |
| Approximate Number of Additions | |||||||||
| 10-1014-02 | 0.25grams | .25grams | 4.11 | .07 | 75.8 | 47.38 | 34.45 | 4.74 | |
| 10-1014-05 | 0.5grams | .5grams | 8.23 | .07 | 158.2 | 98.88 | 71.91 | 9.89 | |
| 10-1014-90 | 100µmoles | .091grams | 1.5 | .07 | 23.6 | 14.75 | 10.73 | 1.48 | |
| Beckman | |||||||||
| Cat.No. | PackSize | Grams/Pack | Dilution(mL) | Molarity | 30nm | 200nm | 1000nm | ||
| Approximate Number of Additions | |||||||||
| 10-1014-02 | 0.25grams | .25grams | 4.11 | .07 | 77.4 | 48.38 | 35.18 | ||
| 10-1014-05 | 0.5grams | .5grams | 8.23 | .07 | 159.8 | 99.88 | 72.64 | ||
| 10-1014-90 | 100µmoles | .091grams | 1.5 | .07 | 25.2 | 15.75 | 11.45 | ||
If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200
AthensResearch&Technology公司位于美国乔治亚州雅典市，从1986年以来一直致力于纯化高纯度，高活性的人类蛋白质和开发这些蛋白的多克隆抗血清。我们的常规产品包括丝氨酸蛋白酶、蛋白酶抑制剂、中性粒细胞酶、载脂蛋白、脂蛋白，血小板蛋白、转铁蛋白、免疫球蛋白等。二十年多年来，世界各地的研究人员都在使用我们公司的产品。在炎症、冠状动脉疾病、自身免疫性疾病、癌症、老年痴呆症等等研究的主要科学出版物中都能看到引用我们公司的产品。我们提供优质，可靠的产品和出色的客户服务。我们期待着您的业务。如果需要定制研究服务，AthensResearch&Technology公司能够根据您的项目要求提供无与伦比的试剂。
公司主要产品：一、凝血因子相关系列产品：包括多款从人血浆、血小板中分离纯化的凝血因子相关蛋白。二、酶及抑制剂系列产品：包括多款从人血浆、红细胞分离纯化的a-抗糜蛋白酶、a1/2抗胰蛋白酶、抗凝血酶、C1酯酶抑制因子、Calpain-1等酶及其抑制剂产品。三、免疫球蛋白系列产品：包括多款从人血浆、骨髓瘤、初乳以及狗和小鼠血浆中分离纯化的免疫球蛋白产品。四、脂蛋白及载脂蛋白系列产品：包括包括多款从人血浆中分离纯化的载脂蛋白及脂蛋白（高密度、中等密度、低密度、极低密度脂蛋白）产品。五、低内毒素蛋白系列产品：包括多款适宜于细胞培养的低内毒素脂蛋白、免疫球蛋白及转铁蛋白产品。六、乳蛋白系列产品：包括从人乳中分离纯化的乳白蛋白、乳铁传递蛋白及分泌型免疫球蛋白A。七、中性粒细胞源蛋白系列产品：包括多款纯化分离自人中性粒细胞的Azurocidin 、CathepsinG及Lactoferrin等蛋白产品。八、血小板相关系列产品：包括纯化分离自人血小板的血小板因子4及凝血酶致敏蛋白。九、转铁蛋白及脱铁转铁蛋白（APOTRANSFERRINS）系列产品：包括多款纯化分离自人、大小鼠、狗及食蟹猴血浆中的转铁蛋白/脱铁转铁蛋白，可应用于细胞或组织培养。十、抗体系列产品：包括多款兔、大鼠、羊源的多克隆抗体产品。
ebiomall.com
